The technology is now being adapted to help detect breast cancer and heart disease
University of Leicester researchers have won an award for their work using artificial intelligence to detect Covid-19.
Prof Yudong Zhang and Dr Shuihua Wang developed software which analyses chest CT scans and uses algorithms to diagnose the virus.Computer science publisher Elsevier said their work earned its 2022 Best Paper Award for Information Fusion."This award means our work has been recognized by a panel of top experts.
"We hope that, in the future, this type of AI technology will allow for automated computer diagnosis without the need for any bit of manual intervention to create a smarter, more efficient healthcare service."Currently most Covid-19 detection is based on PCR tests which can produce false negatives when the physical effects of an illness lag behind their cause.
The researchers said AI could offer an opportunity to screen rapidly and effectively monitor virus cases on a large scale, reducing the burden on doctors.The researchers said they would develop the technology further in the hope it could replace the need for radiologists to diagnose Covid-19 in clinics.
They also want to adapt and expand the software to detect and diagnose breast cancer and cardiovascular diseases.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Increased interleukin-6 is associated with long COVID-19: a systematic review and meta-analysis - Infectious Diseases of PovertyBackground Coronavirus disease 2019 (COVID-19) can involve persistence, sequelae, and other clinical complications that last weeks to months to evolve into long COVID-19. Exploratory studies have suggested that interleukin-6 (IL-6) is related to COVID-19; however, the correlation between IL-6 and long COVID-19 is unknown. We designed a systematic review and meta-analysis to assess the relationship between IL-6 levels and long COVID-19. Methods Databases were systematically searched for articles with data on long COVID-19 and IL-6 levels published before September 2022. A total of 22 published studies were eligible for inclusion following the PRISMA guidelines. Analysis of data was undertaken by using Cochran's Q test and the Higgins I-squared (I2) statistic for heterogeneity. Random-effect meta-analyses were conducted to pool the IL-6 levels of long COVID-19 patients and to compare the differences in IL-6 levels among the long COVID-19, healthy, non-postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (non-PASC), and acute COVID-19 populations. The funnel plot and Egger's test were used to assess potential publication bias. Sensitivity analysis was used to test the stability of the results. Results An increase in IL-6 levels was observed after SARS-CoV-2 infection. The pooled estimate of IL-6 revealed a mean value of 20.92 pg/ml (95% CI = 9.30–32.54 pg/ml, I2 = 100%, P | 0.01) for long COVID-19 patients. The forest plot showed high levels of IL-6 for long COVID-19 compared with healthy controls (mean difference = 9.75 pg/ml, 95% CI = 5.75–13.75 pg/ml, I2 = 100%, P | 0.00001) and PASC category (mean difference = 3.32 pg/ml, 95% CI = 0.22–6.42 pg/ml, I2 = 88%, P = 0.04). The symmetry of the funnel plots was not obvious, and Egger’s test showed that there was no significant small study effect in all groups. Conclusions This study showed that increased IL-6 correlates with long COVID-19. Such an informative revelation suggests IL-
Read more »
Leicester: Motorcyclist dies after lamp-post crashLeicestershire Police say the force has referred the incident to the police watchdog.
Read more »
NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescentResearch reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.
Read more »
Iheanacho faces a race to be fit for Leicester City’s survival run-in, says SmithStriker Kelechi Iheanacho faces a race to be fit for Leicester City’s survival run-in, according to Foxes boss Dean Smith...
Read more »
Dean Smith 'doesn't agree' with fixture schedule but insists Leicester 'will deal with it'Dean Smith believes the relentless Premier League fixture schedule puts extra pressure on Leicester City in the race for survival.
Read more »
Local elections: Leicester mayor role under spotlight as vote nearsVoters will be asked to pick the person for the powerful position at the heart of the city's politics.
Read more »